IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 3 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $686 | +18.7% | 60 | 0.0% | 0.00% | – |
| Q3 2023 | $578 | -56.2% | 60 | -51.6% | 0.00% | – |
| Q2 2023 | $1,319 | +109.0% | 124 | +106.7% | 0.00% | – |
| Q1 2023 | $631 | -15.1% | 60 | 0.0% | 0.00% | – |
| Q4 2022 | $743 | -25.7% | 60 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 60 | -33.3% | 0.00% | – |
| Q2 2022 | $1,000 | 0.0% | 90 | 0.0% | 0.00% | – |
| Q1 2022 | $1,000 | 0.0% | 90 | +50.0% | 0.00% | – |
| Q4 2021 | $1,000 | 0.0% | 60 | 0.0% | 0.00% | – |
| Q3 2021 | $1,000 | 0.0% | 60 | 0.0% | 0.00% | – |
| Q2 2021 | $1,000 | 0.0% | 60 | 0.0% | 0.00% | – |
| Q1 2021 | $1,000 | – | 60 | 0.0% | 0.00% | – |
| Q4 2020 | $0 | – | 60 | 0.0% | 0.00% | – |
| Q3 2020 | $0 | – | 60 | 0.0% | 0.00% | – |
| Q2 2020 | $0 | – | 60 | -25.0% | 0.00% | – |
| Q1 2020 | $0 | -100.0% | 80 | -14.0% | 0.00% | -100.0% |
| Q4 2019 | $1,000 | 0.0% | 93 | -31.1% | 0.00% | – |
| Q3 2019 | $1,000 | 0.0% | 135 | +3.8% | 0.00% | – |
| Q2 2019 | $1,000 | -50.0% | 130 | -11.6% | 0.00% | – |
| Q1 2019 | $2,000 | – | 147 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 1,520,000 | $19,562,000 | 18.54% |
| Sarissa Capital Management LP | 16,390,000 | $210,939,000 | 16.77% |
| Healthcare Value Capital, LLC | 200,000 | $2,574,000 | 5.13% |
| Camber Capital Management LP | 7,500,000 | $96,525,000 | 3.25% |
| 13D Management LLC | 650,455 | $8,371,000 | 2.88% |
| BRIDGER MANAGEMENT, LLC | 2,035,114 | $26,192,000 | 2.44% |
| Brown Capital Management | 18,484,759 | $237,899,000 | 1.80% |
| Healthcare Value Capital, LLC | 50,000 | $644,000 | 1.28% |
| Zebra Capital Management LLC | 53,359 | $687,000 | 0.80% |
| PRICE MICHAEL F | 520,000 | $6,692,000 | 0.74% |